|
[Related PubMed/MEDLINE]
Total Number of Papers: 1775
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
"Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland". |
CSVD, DSST, MCI, TMT |
| 2 |
2020 |
A Comparison of Divergent Thinking Abilities Between Healthy Elderly Subjects and MCI Patients: Preliminary Findings and Implications. |
ATTA, CR, DT, HC, MCI |
| 3 |
2020 |
A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer's Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment. |
AD, PTP, PTPr |
| 4 |
2020 |
A Danish version of the Oxford cognitive screen: a stroke-specific screening test as an alternative to the MoCA. |
OCS |
| 5 |
2020 |
A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF). |
AF, MCI, Swiss-AF |
| 6 |
2020 |
A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. |
CI, CNS, HIV, HR, SOT |
| 7 |
2020 |
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol. |
ADAS, CGM, MCI, T2DM |
| 8 |
2020 |
A Rare Case of Ganser Syndrome: Psychogenic or Organic? |
GS, TBI |
| 9 |
2020 |
A Reliable Tool for Assessing MCI and Dementia: Validation Study of DemTect for Turkish Population. |
MCI, MMSE, QMCI-TR, SMC |
| 10 |
2020 |
A short digital eye-tracking assessment predicts cognitive status among adults. |
CN, DSC, DT, MCI, NIHTB-CB, VPC |
| 11 |
2020 |
A single-arm feasibility study of community-delivered Baduanjin (Qigong practice of the eight Brocades) training for frail older adults. |
BDJ, FES, GDS, MQ, PPA, TUG |
| 12 |
2020 |
A Validation Study of the Remotely Administered Montreal Cognitive Assessment Tool in the Elderly Japanese Population. |
FTF, HC, ICCs, MCI, VTC |
| 13 |
2020 |
Ability of the Maze Navigation Test, Montreal Cognitive Assessment, and Trail Making Tests A & B to predict on-road driving performance in current drivers diagnosed with dementia. |
MNT, OTRS |
| 14 |
2020 |
Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. |
IRP, MMSE, SLE |
| 15 |
2020 |
Action observation combined with gait training to improve gait and cognition in elderly with mild cognitive impairment A randomized controlled trial. |
AO, AOGT, CT, GT, MCI |
| 16 |
2020 |
AD8 patient-informant discrepancy predicts insight and cognitive impairment in Alzheimer's disease. |
GDS |
| 17 |
2020 |
Age Moderates Associations of Hypertension, White Matter Hyperintensities, and Cognition. |
SBP, WMH |
| 18 |
2020 |
Alcohol-related brain injury: An unrecognized problem in acute medicine. |
ARBI |
| 19 |
2020 |
Altered Dynamic Neural Activity in the Default Mode Network in Lung Cancer Patients After Chemotherapy. |
ALFF, dALFF, DMN, dReHo, ReHo, rs-fMRI |
| 20 |
2020 |
Altered Effective Connectivity of Bilateral Hippocampus in Type 2 Diabetes Mellitus. |
DMN, EC, HC, LHIP, RHIP, T2DM |
| 21 |
2020 |
Alzheimer disease starts in childhood in polluted Metropolitan Mexico City. A major health crisis in progress. |
AD, APOE, BAEPs, CFDNPs, CPM 2.5, MMC |
| 22 |
2020 |
An exploratory randomized sub-study of light-to-moderate intensity exercise on cognitive function, depression symptoms and inflammation in older adults with heart failure. |
BDI-IA, HF, RB, TAU, TC |
| 23 |
2020 |
Apolipoprotein E polymorphism carriers exhibit objective cognitive deficits: a single center trial. |
MMSE |
| 24 |
2020 |
Are Standard Follow-Up Parameters Sufficient to Protect Neurocognitive Functions in Patients with Diabetes Mellitus who Underwent Coronary Artery Bypass Grafting? |
--- |
| 25 |
2020 |
Assessing performance on the Montreal Cognitive Assessment (MoCA) in experienced cochlear implant users: use of alternative scoring guidelines. |
HI |
| 26 |
2020 |
Assessment of Speech Understanding After Cochlear Implantation in Adult Hearing Aid Users: A Nonrandomized Controlled Trial. |
CNC, HA, HUI3, MCI, SSQ49 |
| 27 |
2020 |
Association between Ankle Brachial Index, Brachial-Ankle Pulse Wave Velocity, and Mild Cognitive Impairment in Patients with Acute Lacunar Infarction. |
ABI, ALI, baPWV, CI, MCI, OR |
| 28 |
2020 |
Association between cognitive function and asthma in adults. |
CI, FEV1, OR |
| 29 |
2020 |
Association between different coping styles and health-related quality of life in people with Parkinson's disease: a cross-sectional study. |
BDI, MDS, NMS-Quest, UPDRS |
| 30 |
2020 |
Association between NMD3 and symptoms of Parkinson's disease in Chinese patients. |
GWAS, MDS-UPDRS, MMSE, PD, SNP, SS-16 |
| 31 |
2020 |
Association between serum NPTX2 and cognitive function in patients with vascular dementia. |
AD, ELISA, NPTX2, VaD |
| 32 |
2020 |
Association Between Somatization and Nonmotor Symptoms Severity in People With Parkinson Disease. |
MDS-UPDRS, NMSS, PD |
| 33 |
2020 |
Association between the variability of cerebral oxygen saturation during cardiopulmonary bypass and delayed postoperative neurocognitive recovery in cardiac valve surgical patients: A pilot study. |
BIS, CPB, MAP, MMSE |
| 34 |
2020 |
Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. |
Abeta42, CI, CVR, MCI |
| 35 |
2020 |
Association of diabetes status with cognitive impairment in two Chinese rural communities. |
CSPP, FPG |
| 36 |
2020 |
Association of Low-Density Lipoprotein Receptor-Related Protein 1 and Its rs1799986 Polymorphism With Mild Cognitive Impairment in Chinese Patients With Type 2 Diabetes. |
AVLT, LRP1, MCI, OR, sLRP1, T2DM |
| 37 |
2020 |
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. |
AIR, CAT, GAD-7, HADS, MCI, mMRC, OR, PSQI |
| 38 |
2020 |
Association of mild cognitive impairment and metabolic syndrome in patients with hypertension. |
HDL, MCI, MetS |
| 39 |
2020 |
Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients. |
HRQoL, PD, PDCB, PDQ-8 |
| 40 |
2020 |
Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder. |
BDNF, PD, PDSS-CV |
| 41 |
2020 |
Associations Between Measures of Auditory Function and Brief Assessments of Cognition. |
--- |
| 42 |
2020 |
Associations between Trace Elements and Cognitive Decline: An Exploratory 5-Year Follow-Up Study of an Elderly Cohort. |
CTR, MMSE, RES, TE |
| 43 |
2020 |
Associations between unmet palliative care needs and cognitive impairment in a sample of diverse, community-based older adults. |
PC |
| 44 |
2020 |
Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid. |
AD, CBF, CN, MCI, PET, sPDGFRbeta |
| 45 |
2020 |
Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis. |
CASI, RANKL |
| 46 |
2020 |
Associations of Plasma BACE1 Level and BACE1 C786G Gene Polymorphism with Cognitive Functions in Patients with Type 2 Diabetes: A Cross- Sectional Study. |
BACE1, MCI, T2DM |
| 47 |
2020 |
Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study. |
AD, CDRSB, FAQ, MMSE, RAVLT, WMHs |
| 48 |
2020 |
Atherosclerosis, its risk factors, and cognitive impairment in older adults. |
ASCVD, BMI, LVEF, MI |
| 49 |
2020 |
Autonomic Nervous System and Cognitive Impairment in Older Patients: Evidence From Long-Term Heart Rate Variability in Real-Life Setting. |
ANS, BP, HF, HR, HRV, LF, MMSE, RMSSD, SDNN |
| 50 |
2020 |
Brain iron deposition is linked with cognitive severity in Parkinson's disease. |
PD, QSM |
| 51 |
2020 |
Calgary Normative Study: design of a prospective longitudinal study to characterise potential quantitative MR biomarkers of neurodegeneration over the adult lifespan. |
CNS, MR |
| 52 |
2020 |
Carotid Intima-media Thickness, Cognitive Performance and Cognitive Decline in Stroke-free Middle-aged and Older Adults. The Atahualpa Project. |
CIMT |
| 53 |
2020 |
Caudate nuclei volume alterations and cognition and mood dysfunctions in adolescents with single ventricle heart disease. |
BAI, GMI, PHQ-9, SVHD |
| 54 |
2020 |
Cerebral functional activity and connectivity changes in anti-N-methyl-D-aspartate receptor encephalitis: A resting-state fMRI study. |
ALFF, FC, HAMA, MRI, NMDAR, PCC |
| 55 |
2020 |
Cerebral Functional Manipulation of Repetitive Transcranial Magnetic Stimulation in Cognitive Impairment Patients After Stroke: An fMRI Study. |
DLPFC, fALFF, FC, MMSE, PSCI, rs-fMRI, rTMS |
| 56 |
2020 |
Cerebroarterial pulsatility and resistivity indices are associated with cognitive impairment and white matter hyperintensity in elderly subjects: A phase-contrast MRI study. |
CDR, gCBF, PC-MRI, PI, RI, WMH |
| 57 |
2020 |
Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy. |
ART, DTG, EVG, IQR |
| 58 |
2020 |
Changes in Spatial Working Memory in Stable Chronic Obstructive Pulmonary Disease: A Retrospective Study. |
CAVLT, COPD, DS, HC, VFT |
| 59 |
2020 |
Classifying Mild Cognitive Impairment from Behavioral Responses in Emotional Arousal and Valence Evaluation Task - AI Approach for Early Dementia Biomarker in Aging Societies. |
AI, MCI, ML, WHO |
| 60 |
2020 |
Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study. |
FAB, FAST, MDD, Rey I, SNRIs, Span F, SSRIs |
| 61 |
2020 |
Clinical efficacy and safety of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment. |
VCI |
| 62 |
2020 |
Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine. |
Abeta42, ACh, AD, ADAS-Cog, ADL, CM-SS, MMSE |
| 63 |
2020 |
Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements. |
CDEs, DD, HDRS, NINDS, PD, PDBP, UPDRS, UPSIT |
| 64 |
2020 |
Clock-drawing test in vascular mild cognitive impairment: Validity of quantitative and qualitative analyses. |
CDT, MMSE, NC, ROC, VMCI |
| 65 |
2020 |
Clock-drawing test: Normative data of three quantitative scoring methods for Chinese-speaking adults in Shijiazhuang City and clinical utility in patients with acute ischemic stroke. |
CDT |
| 66 |
2020 |
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure. |
6MWD, CI, QOL, SPPB |
| 67 |
2020 |
Cognitive and behavioral status in Japanese ALS patients: a multicenter study. |
ALS, FAB, FTD |
| 68 |
2020 |
Cognitive change after electroconvulsive therapy in mood disorders measured with the Montreal Cognitive Assessment. |
MDE |
| 69 |
2020 |
Cognitive changes in patient living with HIV-AIDS and apolipoprotein-E polymorphism: is there an association? |
MMSE |
| 70 |
2020 |
Cognitive Dysfunction in Patients with Chronic Kidney Disease. |
CKD, eGFR, HD, MMSE |
| 71 |
2020 |
Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy. |
IC, NPC |
| 72 |
2020 |
Cognitive dysfunction in Sjogren's syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics: A cross-sectional study. |
ANAM, pSS, sSS |
| 73 |
2020 |
Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation. |
HSCT |
| 74 |
2020 |
Cognitive impairment and neuropsychiatric manifestations of neurobrucellosis. |
BAI, BDI, WMS-R |
| 75 |
2020 |
Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol. |
ASDI, HADS, IES-R |
| 76 |
2020 |
Cognitive impairment in chronic migraine: a cross-sectional study in a clinic-based sample. |
CM, DSST, EM, OR, RAVLT |
| 77 |
2020 |
Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand. |
MA, MINI |
| 78 |
2020 |
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. |
EF, GC, Neuro-QoL, PD |
| 79 |
2020 |
Cognitive Impairment in Patients with Ankylosing Spondylitis. |
AS |
| 80 |
2020 |
Cognitive outcomes after unruptured intracranial aneurysm treatment with endovascular coiling. |
UIAs |
| 81 |
2020 |
Cognitive performance is associated with worse prognosis in patients with heart failure with reduced ejection fraction. |
HF, HRQoL, KCCQ, MACEs |
| 82 |
2020 |
Cognitive Profile of Patients With Mitochondrial Chronic Progressive External Ophthalmoplegia. |
BNT, CPEO, NMDAS, TMT-B |
| 83 |
2020 |
Cognitive Screening in Geriatric Patients with Atrial Fibrillation Evaluated for Falls. |
AF, FI, MMSE, MTA, WMH |
| 84 |
2020 |
Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment. |
HD, MMSE, ROC |
| 85 |
2020 |
Cognitive state, substance use patterns and outcome after discharge from Kfar Izun, a unique rehabilitation facility. |
--- |
| 86 |
2020 |
Cognitive test results are associated with mortality and rehospitalization in heart failure: Swedish prospective cohort study. |
CI, HF, HR |
| 87 |
2020 |
Combining cognitive stimulation therapy and fall prevention exercise (CogEx) in older adults with mild to moderate dementia: a feasibility randomised controlled trial. |
CogEx, CogEx, CST, PLwD |
| 88 |
2020 |
Comparative Study of Two Short-Form Versions of the Montreal Cognitive Assessment for Screening of Post-Stroke Cognitive Impairment in a Chinese Population. |
CI, PSCI, SF-MoCA |
| 89 |
2020 |
Comparison of driving capacity among patients with amyotrophic lateral sclerosis and healthy controls using the lane change task. |
ALS, ALS-CBS, ALSFRS-R, HC, LCT |
| 90 |
2020 |
Comparison of neurocognitive changes among newly diagnosed tuberculosis patients with and without dysglycaemia. |
2hPP, BSI, CFQ, CVLT, FPG, IFG, IGT, OGTT, QLI, TB |
| 91 |
2020 |
Comparison of the Accuracy of Short Cognitive Screens Among Adults With Cognitive Complaints in Turkey. |
AD, aMCI, Qmci-TR, SCC |
| 92 |
2020 |
Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease. |
CI, MMSE, PANDA, PD |
| 93 |
2020 |
Construct validity of the Visual Cognitive Assessment Test (VCAT)-a cross-cultural language-neutral cognitive screening tool. |
AD, MCI, MMSE, ROC, VCAT |
| 94 |
2020 |
Construction and evaluation of multidomain attention training to improve alertness attention, sustained attention, and visual-spatial attention in older adults with mild cognitive impairment: A randomized controlled trial. |
GEE, MCI |
| 95 |
2020 |
Contralateral delay activity is not a robust marker of cognitive function in older adults at risk of mild cognitive impairment. |
CDA, MCI |
| 96 |
2020 |
Correlation Between Cognition and Balance Among Middle-Aged and Older Adults Observed Through a Tai Chi Intervention Program. |
BMI, TC |
| 97 |
2020 |
Correlation of changes in serum S100beta, NSE and inflammatory factor levels with MMSE and MoCA in intracranial tumor patients with cognitive impairment. |
CT, IL-6, MMSE, NSE, TNF-alpha |
| 98 |
2020 |
Cortical cerebral microinfarcts predict cognitive decline in memory clinic patients. |
CMIs |
| 99 |
2020 |
Cortical Damage Associated With Cognitive and Motor Impairment in Hereditary Spastic Paraplegia: Evidence of a Novel SPAST Mutation. |
AD, FA, HSP, MD, RD |
| 100 |
2020 |
Dawson's Fingers in Cerebral Small Vessel Disease. |
CMB, CSVD, DM, MMSE, MRIs, WMH |
|
A Search Service for Abbreviation / Long Form
